Literature DB >> 24462815

Fibromyalgia and cytokines.

Ignasi Rodriguez-Pintó1, Nancy Agmon-Levin2, Amital Howard3, Yehuda Shoenfeld4.   

Abstract

Fibromyalgia is a common chronic pain syndrome characterized by widespread pains and characteristic somatic symptoms. Current evidence suggests that cytokines and especially chemokines may have a role in the pathogenesis of this syndrome. Cytokines are small soluble factors that work as immune system messengers. They can be classified as pro-inflammatory and anti-inflammatory cytokines. Chemokines are a special kind of pro-inflammatory cytokines that guide the movement of circulating mononuclear cells to the injured side. Some pro-inflammatory cytokine levels (i.e. IL-1RA, IL-6, and IL-8) and, recently, some chemokines' levels have been found to be increased in patients with fibromyalgia. Thus, herein we review the current knowledge regarding the role of cytokines in fibromyalgia patients and their possible clinical relevance.
Copyright © 2014. Published by Elsevier B.V.

Entities:  

Keywords:  Biologic markers; Chemokines; Cytokines; Fibromyalgia; Pain

Mesh:

Substances:

Year:  2014        PMID: 24462815     DOI: 10.1016/j.imlet.2014.01.009

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  38 in total

1.  Serial whole-body cryotherapy in fibromyalgia is effective and alters cytokine profiles.

Authors:  Philipp Klemm; Johanna Becker; Iris Aykara; Thomas Asendorf; Gabriel Dischereit; Elena Neumann; Ulf Müller-Ladner; Uwe Lange
Journal:  Adv Rheumatol       Date:  2021-01-13

2.  Evaluation of blood neutrophil-lymphocyte ratio and platelet distribution width as inflammatory markers in patients with fibromyalgia.

Authors:  Semra Aktürk; Raikan Büyükavcı
Journal:  Clin Rheumatol       Date:  2017-05-02       Impact factor: 2.980

3.  Inflammation, psychiatric symptoms, and opioid use are associated with pain and disability in patients with cirrhosis.

Authors:  Shari S Rogal; Klaus Bielefeldt; Ajay D Wasan; Francis E Lotrich; Susan Zickmund; Eva Szigethy; Andrea F DiMartini
Journal:  Clin Gastroenterol Hepatol       Date:  2014-11-05       Impact factor: 11.382

4.  Silicone breast implants and depression, fibromyalgia and chronic fatigue syndrome in a rheumatology clinic population.

Authors:  Thomas Khoo; Susanna Proudman; Vidya Limaye
Journal:  Clin Rheumatol       Date:  2019-01-31       Impact factor: 2.980

Review 5.  Neurogenic inflammation in fibromyalgia.

Authors:  Geoffrey Littlejohn; Emma Guymer
Journal:  Semin Immunopathol       Date:  2018-03-19       Impact factor: 9.623

Review 6.  Fibromyalgia syndrome in need of effective treatments.

Authors:  Theoharis C Theoharides; Irene Tsilioni; Lauren Arbetman; Smaro Panagiotidou; Julia M Stewart; Rae M Gleason; Irwin J Russell
Journal:  J Pharmacol Exp Ther       Date:  2015-08-25       Impact factor: 4.030

Review 7.  Neurogenic neuroinflammation in fibromyalgia and complex regional pain syndrome.

Authors:  Geoffrey Littlejohn
Journal:  Nat Rev Rheumatol       Date:  2015-08-04       Impact factor: 20.543

8.  Neuropeptides CRH, SP, HK-1, and Inflammatory Cytokines IL-6 and TNF Are Increased in Serum of Patients with Fibromyalgia Syndrome, Implicating Mast Cells.

Authors:  Irene Tsilioni; Irwin J Russell; Julia M Stewart; Rae M Gleason; Theoharis C Theoharides
Journal:  J Pharmacol Exp Ther       Date:  2016-01-13       Impact factor: 4.030

Review 9.  The Role of Vitamin D in the Management of Chronic Pain in Fibromyalgia: A Narrative Review.

Authors:  Hannah W Haddad; Allison C Jumonville; Katarina J Stark; Shavonne N Temple; Chukwudum C Dike; Elyse M Cornett; Alan D Kaye
Journal:  Health Psychol Res       Date:  2021-06-28

10.  Pro-inflammatory Cytokines and Oxidized Low-Density-Lipoprotein in Patients With Fibromyalgia.

Authors:  Funda Canpolat Kutu; Şenay Özdolap; Selda Sarikaya
Journal:  Arch Rheumatol       Date:  2018-08-16       Impact factor: 1.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.